ALK and neuroblastoma: Recent analysis of relapsed neuroblastomas has shown an increased frequency of activating ALK mutations in these patients, and studies using deep sequencing revealed the occurrence of subclonal ALK mutations already at diagnosis, further pointing at the importance of ALK regulation in neuroblastoma etiology [29,30].